Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: IA Carboplatin + Radiotherapy in Relapsing GBM [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating intra-arterial carboplatin with radiotherapy for relapsed glioblastoma, currently recruiting for Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Glioblastoma Multiforme, Relapse | Phase 1, Phase 2 | Status: RECRUITING